About: BAFF overexpression is associated with autoantibody production in autoimmune diseases

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BAFF overexpression is associated with autoantibody production in autoimmune diseases Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 2005

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2005 (uk) im Juni 2005 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 2005 (ast) scientific article published on 01 June 2005 (en)
publication date	wds:Q80367249-0FCA62A3-8BAB-4884-A340-833F38E9CA3E
publication date	2005-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q80367249-6897DA5E-37AD-4A07-9086-B311210B0384
language of work or name	English
author name string	wds:Q80367249-185F9BE8-49A2-4663-9069-63BB98FA329E wds:Q80367249-42C15052-D177-4737-87D9-824499927217 wds:Q80367249-86931B7F-05F6-4085-9825-5F89D7AE85A9 wds:Q80367249-E72CAE62-3076-43EB-8DC7-77620A91B252 wds:Q80367249-F200073D-46D8-499C-8506-89560E739564 wds:Q80367249-FB1FF2DD-A83B-49EF-BE17-5E2D4B3F8A33
author name string	Alain Saraux Sandrine Jousse Valérie Devauchelle Capucine Daridon Christophe Jamin Jacques-Olivier Pers
rdfs:label	BAFF overexpression is associated with autoantibody production in autoimmune diseases (en) BAFF overexpression is associated with autoantibody production in autoimmune diseases (nl)
skos:prefLabel	BAFF overexpression is associated with autoantibody production in autoimmune diseases (en) BAFF overexpression is associated with autoantibody production in autoimmune diseases (nl)
name	BAFF overexpression is associated with autoantibody production in autoimmune diseases (en) BAFF overexpression is associated with autoantibody production in autoimmune diseases (nl)
author	wds:Q80367249-FF6C94DA-FD90-4A87-8FEF-EB391C0CB051
author	Pierre Youinou
title	wds:Q80367249-8686E868-F9B2-4907-9D7F-F4F6121124C8
title	BAFF overexpression is associated with autoantibody production in autoimmune diseases (en)
page(s)	wds:Q80367249-56E72A23-36B3-4246-B1C1-70272D971AE0
page(s)	34-39
instance of	wds:Q80367249-C804C3B8-83C2-4645-A6CA-377B4AF444F4
instance of	scholarly article
PubMed ID	wds:Q80367249-01AD9B60-26CA-4C4E-B29C-88DD78C1C2DF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16014518
PubMed ID	16014518
published in	wds:Q80367249-A76D81E2-43B3-4EF8-B5D3-063EAFC42AC7
published in	Annals of the New York Academy of Sciences
volume	wds:Q80367249-8A572A1E-A6A3-44BA-9A0C-11EFCE315A6F
volume	1050
DOI	wds:Q80367249-4E629067-2C8B-4DDA-9BFF-F2DEABF6EA67
DOI	http://dx.doi.org/10.1196/ANNALS.1313.004
DOI	10.1196/ANNALS.1313.004
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80367249
is cites work of	BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism The search for lupus biomarkers Update on Pathogenesis of Sjögren's syndrome Differential expression of BAFF and its receptors in discoid lupus erythematosus patients Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies BAFF is increased in renal transplant patients following treatment with alemtuzumab B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome Biomarkers in systemic lupus erythematosus: challenges and prospects for the future BAFF: a local and systemic target in autoimmune diseases Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis AIRE regulates T-cell-independent B-cell responses through BAFF. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases Biomarkers for systemic lupus erythematosus B-cell depletion and repopulation in autoimmune diseases Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study Aberrant Epstein-Barr viral infection in systemic lupus erythematosus Breaking old paradigms: Th17 cells in autoimmune arthritis Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome. BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedure B effector cells in rheumatoid arthritis and experimental arthritis Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus The role of aldosterone blockade in murine lupus nephritis Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome The generation and maintenance of serum alloantibody. MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF). Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection B-cell self-tolerance in humans Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice B-cell-directed therapy for inflammatory skin diseases Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells Systemic increase in type I interferon activity in Sjögren's syndrome: a putative role for plasmacytoid dendritic cells TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer B Cell in Autoimmune Diseases New insights into the immunopathogenesis of systemic lupus erythematosus. Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation Autophagy: controlling cell fate in rheumatic diseases Curcumin protects against collagen-induced arthritis via suppression of BAFF production Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases Synthetic peptides containing ITIM-like sequences of IREM-1 inhibit BAFF-mediated regulation of interleukin-8 expression and phagocytosis through SHP-1 and/or PI3K. The future of biologic agents in the treatment of Sjögren's syndrome B-cell survival factors in autoimmune rheumatic disorders

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software